Zhangnan Liu

463 citations
6 papers · 276 indexed · 1 hit paper · h-index 6
Topics
Cancer, Hypoxia, and Metabolism (3 papers)RNA modifications and cancer (2 papers)Immune Cell Function and Interaction (2 papers)
Partner nations
China

In The Last Decade

Zhangnan Liu

6 papers receiving 274 citations

Hit Papers

PD-1 signaling limits expression of phospholipid phosphat...20242026202520241020304050

Peers

Zhangnan Liu
Comparison fields: 5 of 69
  • Molecular Biology 148
  • Cancer Research 103
  • Immunology 64
  • Oncology 41
  • Pulmonary and Respiratory Medicine 39
Replace Elisa Pardella with:
Elisa Pardella Italy
Dianheng Wang China
Mailin Li United States
Hao-Ran Jin China
Adrián Benito Spain
Amber N. Habowski United States
Daniela Danková Denmark
Xinying Qian China
Ellen Karasik United States
Fuad J. Naser United States
Zhangnan Liu relative to Elisa Pardella Italy Elisa Pardella's profile →
Citations per field
00.5×1.5×
Elisa Pardella · 1×
Citations per year

Countries citing papers authored by Zhangnan Liu

Since Specialization
Citations

This map shows the geographic impact of Zhangnan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhangnan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhangnan Liu more than expected).

Fields of papers citing papers by Zhangnan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhangnan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhangnan Liu. The network helps show where Zhangnan Liu may publish in the future.

Co-authorship network of co-authors of Zhangnan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhangnan Liu. A scholar is included among the top collaborators of Zhangnan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhangnan Liu. Zhangnan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 14
2
PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8+ T cell ferroptosisbreakdown →
59
3 23
4 31
5 19
6 130

About Zhangnan Liu

Zhangnan Liu is a scholar working on Biochemistry, Cancer Research and Physiology, having authored 6 papers that have together received 276 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (3 papers), RNA modifications and cancer (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Cancer Research (103 citations), Immunology (64 citations) and Biochemistry (21 citations). Zhangnan Liu has collaborated with scholars based in China. Frequent co-authors include Huijuan Wang, Ming Fan, Xia Li, Dongli Yue, Jieyao Li, Liping Wang, Yi Zhang, Meichen Liu, Xinfeng Chen and Shao-wei Li. Their work appears in journals such as Immunity, Life Sciences and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026